{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"ribose-5-p-isomerase-deficiency","columns":[{"gene":"","key":"population-b6709cfd3d177206d75d","label":"Ribose 5-phosphate isomerase deficiency","mondoId":"MONDO:0012073","onsetQualifier":null,"originColumnKey":"MONDO:0012073/OMIM:608611","originalViews":[{"key":"MONDO:0012073/OMIM:608611","label":"Ribose 5-phosphate isomerase deficiency","scopeLabel":"OMIM:608611","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["01ae5afa0f1c16997c0b928fa819852869378e6514d15e5a4194072e870d299d","0ae75c7d31ca07f005e96726fada405500bd9d358f6b9eba354ff0d6f886b206","12769520cc4c04cdb225dea035e49340af135516938832982e1e2f4fc7fdbb3f","360675e9f7c10fc10044a97e26ece5f1bab6398b1049e4915ccfe51fe18d9299","376d62d8a03cc67f46501f6c06b34f9a694302637a14444546784eea2688dcc7","4b9dcee654ebe0d52e083cb9ddffb6689ece4cdb99d702818e1784f4f61c2420","55bbf47b4caa1d8b3e52c23e1663fe38ab76e5503f7ccd4a2f72a2ec9ccda5d4","574d6e3ac5fdff2d1e4f917a54290d3da069fba57ad187d16d1bfd18f3473f84","59794dc0e445b321076a7b05d34b582a07e50c6e644deabfc0e4b46dcb84d125","817d51984131cca3b28452e9df31cf0425662950739c66c7463c92c756687d01","87e7e98abcf6a66c9ded4d831576e77794a028bed43a41a950d206846c3f2a97","96762b0f2e715a2e1ef112d57423e2be8b479a5f2703cd15c21f13bccdfe35ce","9926814fa766c318e678b6987ba8799146ee1cae7f3e6d219d5328f6555bcb86","99466b5f468d82e8249dcec4bbbb65730bba52abd651cdac8ef3a35d8b9611d2","a022be1b462ce7f30cf55239ea04d8c6703fda6cdd95a12e1e2266c468405dec","a5aaa57cf97ca14659ebad402905c7c1c38337cb7b95f2b0936a6cbbe0eddf10","aaf2ee791276a5b7b9b26dd02d33827d5d758b5a562a2783e4d4560f87168771","add5006dc5617021489b50d757f128f1bce98000f24611248aebecaf276f3060","b6f8bfebb2e7c94e17bde5af08f86fb5aa8a50742ea4d2bd9d339c63cc0dbf78","b7a412d0a98619faf6e361efb021136c979e4ad3e379e68048f6791553287843","bdd8a3b0bccf00270cc433c8496cd2a202b9844abe28b898cf3cc29e2ec6d5c7","d9da0c157324074770d0ea5155b4f6e144564d05e6b4d42676597ef2ff74307b","ea61162bfa49ae0e29418f8271995244f4ad90b7677a30c1c6b67a90cea65ee8","ec60ba01b3c93b63f600e6f81bd66d498777894a9879fbc51ccef68718b0f71b"],"recordQualifiers":{},"scopeLabel":"OMIM:608611","sourceIds":["OMIM:608611"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-b6709cfd3d177206d75d"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001251","HP:0410056","HP:0410055","HP:0001260","HP:0034894","HP:0410057","HP:0025550"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":24,"sourceGroups":{"omim":10,"published":14}},"features":[{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0410056","label":"Decreased CSF erythritol concentration","primary":true},{"hpoId":"HP:0410055","label":"Decreased level of erythritol in urine","primary":true},{"hpoId":"HP:0001260","label":"Dysarthria","primary":true},{"hpoId":"HP:0034894","label":"Elevated brain polyol compounds by MRS","primary":true},{"hpoId":"HP:0410057","label":"Elevated circulating D-threitol concentration","primary":true},{"hpoId":"HP:0025550","label":"Elevated circulating ribitol concentration","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0002311","label":"Incoordination","primary":false},{"hpoId":"HP:0410058","label":"Increased CSF D-threitol concentration","primary":false},{"hpoId":"HP:0410071","label":"Increased CSF ribitol concentration","primary":false},{"hpoId":"HP:0410073","label":"Increased CSF ribose concentration","primary":false},{"hpoId":"HP:0410075","label":"Increased CSF xylitol concentration","primary":false},{"hpoId":"HP:0410059","label":"Increased level of D-threitol in urine","primary":false},{"hpoId":"HP:0410070","label":"Increased level of ribitol in urine","primary":false},{"hpoId":"HP:0410072","label":"Increased level of ribose in urine","primary":false},{"hpoId":"HP:0410074","label":"Increased level of xylitol in urine","primary":false},{"hpoId":"HP:0002352","label":"Leukoencephalopathy","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0001271","label":"Polyneuropathy","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0007141","label":"Sensorimotor neuropathy","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false}],"ledeHtml":"Ribose-5-P isomerase deficiency is an extremely rare, hereditary, disorder of pentose phosphate metabolism characterized by progressive leukoencephalopathy and a highly increased ribitol and D-arabitol levels in the brain and body fluids. Clinical presentation includes psychomotor delay, epilepsy, and childhood-onset slow neurological regression with ataxia, spasticity, optic atrophy and sensorimotor neuropathy.","mondoId":"MONDO:0012073","node":{"canonicalSlug":"ribose-5-p-isomerase-deficiency","comparisons":[{"documentSha256":"8ea50a782ed6165d6e63edb7ce6e9e29df3e72b311b65032a15481807f6b07f2","key":"legacy-ribose-5-p-isomerase-deficiency","kind":"legacy","label":"ribose-5-P isomerase deficiency","memberIds":["MONDO:0012073"],"mondoId":"MONDO:0012073","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/ribose-5-p-isomerase-deficiency.8ea50a782ed6165d6e63edb7ce6e9e29df3e72b311b65032a15481807f6b07f2.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"ribose-5-P isomerase deficiency","paragraphs":["Ribose-5-P isomerase deficiency is an extremely rare, hereditary, disorder of pentose phosphate metabolism characterized by progressive leukoencephalopathy and a highly increased ribitol and D-arabitol levels in the brain and body fluids. Clinical presentation includes psychomotor delay, epilepsy, and childhood-onset slow neurological regression with ataxia, spasticity, optic atrophy and sensorimotor neuropathy."],"scope":"exact","source":"MONDO","upstream":"Orphanet:440706","url":"https://monarchinitiative.org/MONDO:0012073"},"ownColumnKeys":["population-b6709cfd3d177206d75d"],"publication":"published","relationships":[{"kind":"parent","label":"leukodystrophy","mondoId":"MONDO:0019046","slug":"leukodystrophy"},{"kind":"parent","label":"inborn disorder of pentose phosphate metabolism","mondoId":"MONDO:0019231","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Name scope not exact or reviewed","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/17747"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"01ae5afa0f1c16997c0b928fa819852869378e6514d15e5a4194072e870d299d","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"OMIM:608611","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"0ae75c7d31ca07f005e96726fada405500bd9d358f6b9eba354ff0d6f886b206","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0410059","is_excluded":false,"label":"Increased level of D-threitol in urine","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"12769520cc4c04cdb225dea035e49340af135516938832982e1e2f4fc7fdbb3f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002352","is_excluded":false,"label":"Leukoencephalopathy","onset_id":null,"reference":"OMIM:608611","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"360675e9f7c10fc10044a97e26ece5f1bab6398b1049e4915ccfe51fe18d9299","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"OMIM:608611","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"376d62d8a03cc67f46501f6c06b34f9a694302637a14444546784eea2688dcc7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0410073","is_excluded":false,"label":"Increased CSF ribose concentration","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"4b9dcee654ebe0d52e083cb9ddffb6689ece4cdb99d702818e1784f4f61c2420","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0410071","is_excluded":false,"label":"Increased CSF ribitol concentration","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"55bbf47b4caa1d8b3e52c23e1663fe38ab76e5503f7ccd4a2f72a2ec9ccda5d4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001271","is_excluded":false,"label":"Polyneuropathy","onset_id":null,"reference":"OMIM:608611","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"574d6e3ac5fdff2d1e4f917a54290d3da069fba57ad187d16d1bfd18f3473f84","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0410070","is_excluded":false,"label":"Increased level of ribitol in urine","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"59794dc0e445b321076a7b05d34b582a07e50c6e644deabfc0e4b46dcb84d125","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"OMIM:608611","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"817d51984131cca3b28452e9df31cf0425662950739c66c7463c92c756687d01","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0410056","is_excluded":false,"label":"Decreased CSF erythritol concentration","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"87e7e98abcf6a66c9ded4d831576e77794a028bed43a41a950d206846c3f2a97","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"OMIM:608611","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"96762b0f2e715a2e1ef112d57423e2be8b479a5f2703cd15c21f13bccdfe35ce","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0410058","is_excluded":false,"label":"Increased CSF D-threitol concentration","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"9926814fa766c318e678b6987ba8799146ee1cae7f3e6d219d5328f6555bcb86","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007141","is_excluded":false,"label":"Sensorimotor neuropathy","onset_id":null,"reference":"OMIM:608611","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"99466b5f468d82e8249dcec4bbbb65730bba52abd651cdac8ef3a35d8b9611d2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"OMIM:608611","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"a022be1b462ce7f30cf55239ea04d8c6703fda6cdd95a12e1e2266c468405dec","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":"20/20","hpo_id":"HP:0025550","is_excluded":false,"label":"Elevated circulating ribitol concentration","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a5aaa57cf97ca14659ebad402905c7c1c38337cb7b95f2b0936a6cbbe0eddf10","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0410057","is_excluded":false,"label":"Elevated circulating D-threitol concentration","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"aaf2ee791276a5b7b9b26dd02d33827d5d758b5a562a2783e4d4560f87168771","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0410072","is_excluded":false,"label":"Increased level of ribose in urine","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"add5006dc5617021489b50d757f128f1bce98000f24611248aebecaf276f3060","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:608611","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"b6f8bfebb2e7c94e17bde5af08f86fb5aa8a50742ea4d2bd9d339c63cc0dbf78","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0410075","is_excluded":false,"label":"Increased CSF xylitol concentration","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b7a412d0a98619faf6e361efb021136c979e4ad3e379e68048f6791553287843","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0034894","is_excluded":false,"label":"Elevated brain polyol compounds by MRS","onset_id":null,"reference":"OMIM:608611","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"bdd8a3b0bccf00270cc433c8496cd2a202b9844abe28b898cf3cc29e2ec6d5c7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"OMIM:608611;PMID:31056085","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d9da0c157324074770d0ea5155b4f6e144564d05e6b4d42676597ef2ff74307b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0410055","is_excluded":false,"label":"Decreased level of erythritol in urine","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ea61162bfa49ae0e29418f8271995244f4ad90b7677a30c1c6b67a90cea65ee8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002311","is_excluded":false,"label":"Incoordination","onset_id":null,"reference":"PMID:31056085","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ec60ba01b3c93b63f600e6f81bd66d498777894a9879fbc51ccef68718b0f71b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:608611","disease_name":"Ribose 5-phosphate isomerase deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0410074","is_excluded":false,"label":"Increased level of xylitol in urine","onset_id":null,"reference":"PMID:14988808","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012073\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:440706</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Ribose-5-P isomerase deficiency is an extremely rare, hereditary, disorder of pentose phosphate metabolism characterized by progressive leukoencephalopathy and a highly increased ribitol and D-arabitol levels in the brain and body fluids. Clinical presentation includes psychomotor delay, epilepsy, and childhood-onset slow neurological regression with ataxia, spasticity, optic atrophy and sensorimotor neuropathy.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012073\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"ribose-5-p-isomerase-deficiency","sourceDocuments":[{"name":"MONDO: ribose-5-P isomerase deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012073"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"ribose-5-P isomerase deficiency"},"schemaVersion":1}
